increasing level of tobacco smoke exposure. In addition, systolic and diastolic blood pressure and BMI were independent predictors of the aortic elasticity indices. In multivariable models, cotinine level (P ϭ .020) and systolic blood pressure (P Ͻ .001) were inversely associated with AC and directly related to SI (cotinine level, P ϭ .005; systolic blood pressure, P ϭ .0003). CONCLUSIONS: These data suggest that passive smoking is associated with decreased aortic elasticity in children, indicating early arterial changes. 
CONCLUSIONS: RF is not uncommon in children Ͻ5 years of age. Subclinical carditis should be anticipated and looked for at the right time in susceptible patients, particularly those with rheumatic arthritis and chorea. Multicenter studies should be carried out for the addition of the echocardiographic features of carditis to Jones' minor criteria for the diagnosis of RF. Diagnosis of carditis requires a high index of suspicion in at least 1 of 3 cases. 
EXPERIMENTAL RESEARCH OF

INTRODUCTION:
Simvastatin was predicted to be a potential inhibitor to pulmonary vascular remodeling. This novel reversion induced by simvastatin has remained an uncertain mechanism. OBJECTIVE: Our goal was to explore the role of simvastatin as a potential inhibitor of pulmonary vascular remodeling.
METHODS:
We established a neointimal pulmonary hypertensive rat model receiving monocrotaline after pneumonectomy. Simvastatin was administered after the operation. Hemodynamic and vascular remodeling corresponding indices were detected. GATA-6, a gene transcription factor, was evaluated in vivo. Proliferation and the cellular cycle were assessed in cultured vascular smooth muscle cells (VSMCs). ␣-SM-actin, F-actin, and paxillin were detected to evaluate the phenotype changes. RESULTS: Neointimal changes developed in 88.5% of right lung intraacinar arteries after pneumonectomy and monocrotaline administration. Mean pulmonary artery pressure, the right ventricle/(left ventricle ϩ S) ratio, and media wall thickness significantly increased in rats that had pneumonectomy and were treated with monocrotaline but decreased significantly in simvastatin-treated rats. The expression of GATA-6 markedly decreased in these rats and was significantly upregulated after receiving simvastatin. In vitro, the proliferation was significantly downregulated in VSMCs with simvastatin compared to that with plateletderived growth factor. ␣-SM-actin increased significantly, and F-actin or paxillin was downregulated in simvastatintreated rats. CONCLUSIONS: Our data indicate that simvastatin is most likely a pulmonary vascular remodeling inhibitor, which may reverse the proliferation of VSMCs and phenotype changes. Simvastatin can also upregulate GATA-6 expression in lung tissue.
